The Immunogenicity of CO-expressing Plasmid and Fusion Genes Plasmid Containing IBDV VP2/4/3 and ChIL-18 Genes

HOU Xian-hong,WEI Yong-wei,ZHANG Xiao-dong,YU Lian
DOI: https://doi.org/10.3969/j.issn.1008-0589.2010.10.10
2010-01-01
Abstract:This study evaluated the adjuvant effect of ChIL-18 in several recombinant plasmids,with the aim to develop efficient,inexpensive IBDV DNA vaccines.Two-week-old SPF chickens were randomly divided into 6 groups and immunized with 200 μg recombination plasmids:group A for pCI-VP2/4/3-ChIL-18,group B for pCI-ChIL-18-VP2/4/3,group C for pCI-co-VP2/4/3-ChIL-18,group D for pCI-VP2/4/3,group E for each of pCI-VP2/4/3 and pCI-ChIL-18,group F served as the unvaccinated control.The chickens were boosted with same dosage after two weeks.The immune responses were compared among each testing groups through observing lymphocyte proliferation response of peripheral blood,detecting anti-IBDV neutralization antibody and ELISA antibody level.The results showed that pCI-co-VP2/4/3-ChIL-18 could effectively evoke immune responses in chickens with 93.3% protection rate,followed by pCI-VP2/4/3-ChIL-18 with 80.0% protection rate.There was no significant differences between pCI-ChIL-18-VP2/4/3 and pCI-ChIL-18+pCI-VP2/4/3,both produced 73.3% protection.Immunization with pCI-VP2/4/3 used alone produced 60.0% protection.This study indicated that ChIL-18 could be used as anefficient molecular adjuvant in the development of DNA vaccines against IBDV.
What problem does this paper attempt to address?